|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec's 18th Annual Industry Auditover 6 years ago
Product Development: The Optimizer’s Curseover 6 years ago
Setting Your Launch Pathover 6 years ago
Pre-launch Prep: The Modern Protocolover 6 years ago
The Murky Outlook for Generic Drugsover 6 years ago
Post-Launch Birthday: The Time to Refineover 6 years ago
Product Launch: Five Paths Forwardover 6 years ago
Once Upon a Brandover 6 years ago
Country Report: Chinaover 6 years ago
Other Products to WatchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5